Kesar Petroproducts Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Kesar Petroproducts Ltd is ₹ 23.62 as of 20 Mar 15:30 . The P/E Ratio of Kesar Petroproducts Ltd changed from 95 on March 2021 to 23.4 on March 2025 . This represents a CAGR of -24.44% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Kesar Petroproducts Ltd changed from ₹ 45.92 crore on March 2021 to ₹ 232.6 crore on March 2025 . This represents a CAGR of 38.33% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of Kesar Petroproducts Ltd for the Dec '25 is ₹ 41.33 crore as compare to the Sep '25 revenue of ₹ 50.49 crore. This represent the decline of -18.14% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Kesar Petroproducts Ltd for the Dec '25 is ₹ 6.59 crore as compare to the Sep '25 ebitda of ₹ 7.51 crore. This represent the decline of -12.25% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Kesar Petroproducts Ltd changed from ₹ 2.12 crore to ₹ 2.92 crore over 7 quarters. This represents a CAGR of 20.08% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Kesar Petroproducts Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Kesar Petroproducts Ltd

Promoted in the joint sector by Maharashtra Petrochemicals Corporation and Sobhagya Mercantile, Kesar Petroproducts Limited was incorporated in Jan.'90.
The Company is a leading manufacturers of Phthalocyanine Blue Crude.
It is into manufacturing Phthalocyanine range of pigments and Dye Intermediates. The company has set up a plant at Lote Parshuram, Maharashtra, to produce 5000 tpa of Bisphenol-A (diphenylol propane) in collaboration with Polibur Engineering, UK, with the technology being supplied by the Institute of Chemical Synthetic Organics (ICSO), Poland.
The plant commenced commercial production in Oct.'92.The company's product -- Bisphenol-A -- is an essential raw material in the manufacture of epoxy resin and phenolic resin. In 1999-2000, the company was awarded ISO-9002 certificate by BVQI.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Kesar Petroproducts Ltd or Saroja Pharma Industries India Ltd?

Market cap of Kesar Petroproducts Ltd is 228 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd?

As of March 23, 2026, the Kesar Petroproducts Ltd stock price is INR ₹23.62. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹28.15.

How do dividend payouts of Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Kesar Petroproducts Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.